Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

辐射诱导的癌症风险 辐射诱导的癌症风险

B E Lambert

    Lancet (London, England)
    |May 7, 1988
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Comments on "Impact of tritium around EDF nuclear power plants".

    Journal of radiological protection : official journal of the Society for Radiological Protection·2009
    Same author

    Comments on "Are the risks from tritium exposures being underestimated?".

    Journal of radiological protection : official journal of the Society for Radiological Protection·2009
    Same author

    Systematic review of experimental studies on the relative biological effectiveness of tritium.

    Radiation and environmental biophysics·2007
    Same author

    Uncertainties in dose coefficients for intakes of tritiated water and organically bound forms of tritium by members of the public.

    Radiation protection dosimetry·2002
    Same author

    Chromosomal instability in haemopoietic cells of the foetus, mother and offspring after in utero irradiation of the CBA/Ca mouse.

    International journal of radiation biology·2001
    Same author

    Standards for environmental, non-threshold, carcinogens: a comparison of the approaches used for radiation and for chemicals.

    The Annals of occupational hygiene·1998
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章